Faradarmani: An Introduction - Cont II

Faradarmani: An Introduction - Cont II

 

Purpose of Faradarmani

While Faradarmani is primarily known for its therapeutic applications, its purpose extends beyond mere physical healing. The practice aims to facilitate:

• Practical Acquaintance with Divine Intelligence: Faradarmani provides a tangible experience of the Cosmic T-Consciousness Network (CTCN) is the agent of guidance and management of the Cosmos in which we live. This experience can lead to a deeper understanding of a conscious force at work in the universe, ultimately pointing towards a practical understanding of God.

• Elimination from the me-centredness: The practice encourages individuals to move beyond the confines of their ego and connect with a greater consciousness (CTCN). This shift in perspective can lead to personal transformation and a sense of liberation from self-imposed limitations.

• Practical Worship: By serving others and facilitating their healing through Faradarmani, individuals engage in a form of practical worship.

• Recognition of Inner Treasures: Faradarmani helps individuals tap into their inherent spiritual capabilities and connect with their inner potential.

• Collective Salvation: By promoting healing and well-being, Faradarmani contributes to the overall betterment of humanity and collective salvation.

These objectives highlight that Faradarmani is not simply a treatment modality but a spiritual path that encourages self-discovery, personal growth and connection with a higher consciousness.

Principles of Faradarmani

Faradarmani adheres to several key principles that guide its practice and application:

• Priority of Conventional Medicine: Faradarmani is considered complementary medicine, and conventional medicine is prioritised as the first line of treatment. It is generally recommended for individuals who have not found relief through conventional methods.
• Integration with Medical Supervision: Individuals on medication can use Faradarmani alongside their conventional treatment under the guidance of their doctor. They can also work with their doctor to potentially adjust their medication dosage based on their progress with Faradarmani.
• Multiple Faradarmangar (Fara-healer) or Faradarmangir (Fara-healee): Multiple Faradarmangar can simultaneously work with one Faradarmnagir, and one Faradarmangar can work with multiple Faradarmangir (patients), with no impact on the results. This is because the treatment is facilitated by the CTCN and not the individual skill or ability of the Faradarmangar.
• Universality of Treatment: The type or history of illness, whether congenital, genetic, infectious, psychological, chronic or acute, does not affect the treatment process in Faradarmani. The CTCN addresses the underlying imbalances regardless of the specific manifestation of illness.
• Unlimited Long-Distance Treatment: There are no restrictions on the frequency or duration of long-distance Faradarmani sessions. Faradarmangir (patients) can receive treatment as often as needed, regardless of their location or time zone.
• Equivalence of Long and Short Distance: Long-distance and close-distance Faradarmani sessions are equally effective, and the results are not dependent on the Faradarmangar's abilities or proximity to the Faradarmangir.
• No Negative Karmic Consequences: Practicing Faradarmani is believed to have no negative karmic repercussions because it operates through CTCN.
• Faradarmangar's Role: Faradarmangar are facilitators of the connection but do not possess the power to deem any illness incurable or attribute healing power to themselves. They act as intermediaries for the CTCN.
• Flexibility of Patient's Position: The effectiveness of long-distance Faradarmani is not affected by the Faradarmangir's physical position, whether sitting, standing, lying down, or in motion.
• Readdressing Past and Present Illnesses: Faradarmani can address both current and past illnesses, including those that were not fully resolved previously. The treatment process may reveal symptoms related to these past conditions as they are addressed and resolved.

The process of treatment is initiated according to the patterns displayed by the following graphs:

A: Psychosomatic Disorders:

Psychosomatic disorders are somatic (physical) disorders with psychological/emotional roots.

B: Mento-somatic Disorders: 

Mento-somatic disorders are somatic (physical) disorders with mind-related roots such as worldview problems and wrong beliefs.

C: Mental Disorders:

    

    

D: Psychological/Emotional and Physical Disorders

References

• Cosmointel (2024) Faradarmani Introduction. Available at: https://cosmointel.com/faradarmani-introduction/ (Accessed: 18 October 2024).
• Mataheri (2024) Mataheri International. Available at: https://int.mataheri.com (Accessed: 14 October 2024).
• Erfan Halgheh Academy (2024) Erfan Halgheh Academy. Available at: https://elementary.erfanhalghehacademy.com/?lang=en (Accessed: 14 October 2024).
• Cosmointel (2024) Cosmointel. Available at: https://cosmointel.com/?lang=fa (Accessed: 18 October 2024).
• Journal of Cosmointel (2024) Journal of Cosmointel. Available at: https://www.journalofcosmointel.com/index.php/journalofcosmointel (Accessed: 14 October 2024).
• Taheri, M.A. (2013) Human from Another Outlook. Interuniversal Press. Available at: https://www.amazon.com/gp/product/1939507006 (Accessed: 18 October 2024).
• Taheri, M.A. (2013) Halqeh Mysticism (Interuniversal Mysticism, Vol. 1). Interuniversal Press. Available at: https://www.amazon.com/gp/product/1939507103 (Accessed: 14 October 2024).

• Taheri, M.A. (2014) '4th World Conference on Psychology, Counseling and Guidance WCPCG-2013', Procedia - Social and Behavioral Sciences, 114, pp. 75-79. Available at: https://pdf.sciencedirectassets.com/277811/1-s2.0-S1877042814X0008X/1-s2.0-S1877042813052993/main.pdf (Accessed: 18 October 2024).
• Taheri, M.A., Parazin, M., Ashrafi-Amineh, F. and Joeghan, S.S. (2013) 'The Effect of Faradarmani on General Health', Procedia - Social and Behavioral Sciences, 82, pp. 248-256. Available at: https://pdf.sciencedirectassets.com/277811/1-s2.0-S1877042813X00151/1-s2.0-S1877042813013219/main.pdf (Accessed: 18 October 2024).